<DOC>
	<DOCNO>NCT00818363</DOCNO>
	<brief_summary>This research study test SABER™-Bupivacaine ( experimental pain-relieving medication ) . SABER™-Bupivacaine design continuously deliver bupivacaine , common local anesthetic , day order treat local post-surgical pain . The purpose study investigate safety ( side effect ) associate use SABER™-Bupivacaine well work reduce pain opioid-related side effect follow shoulder surgery .</brief_summary>
	<brief_title>A Safety Effectiveness Study SABER™-Bupivacaine Pain Following Shoulder Surgery</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>Patients must able read understand consent form , provide write consent , complete trialrelated procedure , communicate trial staff . Males female , 18 65 year age , schedule shoulder surgery . Patients must healthy mild systemic disease . Patients must ECG wave form within normal limit Patients must blood pressure within normal range . Male female patient must agree use medically acceptable method contraception throughout entire trial period 1 week trial complete . Patients must refrain strenuous activity avoid change prescribe exercise level throughout course trial . Patients previous arthroscopic surgery open surgery study shoulder . Patients chronic pain condition require continuous use corticosteroid great 3 month . Patients fibromyalgia , rheumatoid arthritis , and/or seronegative inflammatory arthropathy . Patients normal calculated creatinine clearance . Patients pregnant lactate . Patients currently receive 20 mg hydrocodone daily ( equivalent narcotic dose ) routine basis . Patients , Investigator 's opinion , develop opioid tolerance . Patients current regular use anticonvulsant , antiepileptic , antidepressant , monoamine oxidase inhibitor screen . Patients current regular use drug know significantly prolong correct QT interval Patients know hypersensitivity local anesthetic agent amide type ( e.g. , lidocaine , bupivacaine ) . Patients know hypersensitivity opioids . Patients condition contraindicate use opioids . Patients know suspected abuse opioids illicit drug . Patients know suspected alcohol abuse . Participation another clinical trial time within 30 day trial . Patients , Investigator 's opinion , participate trial may capable follow trial schedule reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Postoperative pain</keyword>
	<keyword>shoulder surgery</keyword>
	<keyword>opioid</keyword>
</DOC>